Alcon (ALC) EBITDA Margin (2009 - 2026)

Alcon (ALC) recorded quarterly EBITDA Margin of 10.88% in Q1 2026, down 6.12% quarter-over-quarter from 11.58% in Q4 2025.

Alcon (ALC) EBITDA Margin (2009 - 2026) Analysis & Trends

Alcon's EBITDA Margin history runs 11 years deep, the most recent figure standing at 10.88% for Q1 2026.

In Q1 2026, EBITDA Margin changed N/A year-over-year to 10.88%; the TTM figure through Mar 2026 stood at 11.22% (changed N/A YoY), while the FY2025 annual figure was 13.18%, down 119.0% from the prior year.
EBITDA Margin was 10.88% for Q1 2026 at Alcon, down from 11.58% in the prior quarter.
In the past five years, EBITDA Margin ranged from a high of 15.95% in Q4 2024 to a low of 0.97% in Q4 2022.
Historically, EBITDA Margin has averaged 11.11% across 5 years, with a median of 11.4% in 2022.
Biggest YoY gain for EBITDA Margin was 869 bps in 2022; the steepest drop was 755 bps in 2022.
A 5-year view of EBITDA Margin shows it stood at 0.97% in 2022, then surged by 815 bps to 8.92% in 2023, then surged by 79 bps to 15.95% in 2024, then retreated by 27 bps to 11.58% in 2025, then slipped by 6 bps to 10.88% in 2026.
The last three EBITDA Margin figures came in at 10.88% (Q1 2026), 11.58% (Q4 2025), and 12.82% (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBITDA Margin (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	28.86%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	1.97%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	1.63%
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	34.92%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	20.96%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	4.04%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-9.90%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	13.65%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	2.44%
10	Alcon	25,681.50	-1.66 Bn	1.53 Bn	10.88%

Download Data